CN4 COST-EFFECTIVENESS OF ERLOTINIB COMPARED WITH DOCETAXEL FOR THE TREATMENT OF RELAPSED NONSMALL CELL LUNG CANCER (NSCLC) IN THE UK
G Lewis, L Morlotti, J Creeden, M Gyldmark, MD PeakeVolume:
9
Year:
2006
Language:
english
DOI:
10.1016/s1098-3015(10)63206-8
File:
PDF, 89 KB
english, 2006